Literature DB >> 31576476

The association between matrix metalloproteinase-7 genetic variant and bladder cancer risk in a Chinese Han population.

Fei Mao1, Xiao-Bing Niu1, Shuo Gu1, Lu Ji1, Bing-Jian Wei1, Heng-Bing Wang2.   

Abstract

The circulating matrix metalloproteinase-7 (MMP-7) levels are associated with the risk of bladder cancer (BC). MMP-7 gene -181A/G polymorphism may influence the expression of MMP-7 by affecting the transcriptional activity. A case-control study comprising 355 BC patients and 435 age- and gender-matched healthy controls was conducted in a Chinese Han population. The genotype of MMP-7 gene -181A/G polymorphism was determined by using polymerase chain reaction-restriction fragment length polymorphism method. Data revealed that MMP-7 gene -181A/G polymorphism increased the risk of BC under the homozygous and allelic models. However, no association between MMP-7 gene -181A/G polymorphism and BC risk was obtained after adjusting for age, gender, smoking habits and drinking habits. Subgroup analyses showed MMP-7 gene -181A/G polymorphism was associated with increased risk for BC among the smokers and drinkers. Furthermore, AG or GG genotype of -181A/G polymorphism was associated with larger tumor size and lymphatic metastasis in BC patients. To sum up, MMP-7 gene -181A/G polymorphism is not associated with the susceptibility to BC. However, subgroup analyses obtain significant association among the groups of smokers and drinkers. Larger studies in other ethnic groups are needed to ascertain the contribution of MMP-7 gene -181A/G polymorphism to BC risk.

Entities:  

Keywords:  Bladder cancer; Matrix metalloproteinase-7; Single nucleotide polymorphism

Mesh:

Substances:

Year:  2019        PMID: 31576476     DOI: 10.1007/s10238-019-00582-7

Source DB:  PubMed          Journal:  Clin Exp Med        ISSN: 1591-8890            Impact factor:   3.984


  25 in total

1.  Association between polymorphisms in the biometabolism genes CYP1A1, GSTM1, GSTT1 and GSTP1 in bladder cancer.

Authors:  João Paulo Souto Grando; Hellen Kuasne; Roberta Losi-Guembarovski; Iara Sant'ana Rodrigues; Henrique Mitsu Matsuda; Paulo Emílio Fuganti; Emerson Pereira Gregório; Farid Libos Júnior; Rodrigo Paes de Menezes; Marco Aurélio de Freitas Rodrigues; Ilce Mara de Syllos Cólus
Journal:  Clin Exp Med       Date:  2008-11-01       Impact factor: 3.984

2.  Association of MMP7-181A/G and MMP13-77A/G polymorphisms with colorectal cancer in a Mexican population.

Authors:  J M Moreno-Ortiz; M Gutiérrez-Angulo; M Partida-Pérez; J Peregrina-Sandoval; R Ramírez-Ramírez; R Muñiz-Mendoza; S Suárez-Villanueva; M Centeno-Flores; V Maciel-Gutiérrez; J E Cabrales-Vazquez; M L Ayala-Madrigal
Journal:  Genet Mol Res       Date:  2014-02-14

3.  Matrix metalloproteinase-7 as a marker of metastasis and predictor of poor survival in bladder cancer.

Authors:  Tibor Szarvas; Markus Becker; Frank vom Dorp; Carolin Gethmann; Martin Tötsch; Agnes Bánkfalvi; Kurt W Schmid; Imre Romics; Herbert Rübben; Süleyman Ergün
Journal:  Cancer Sci       Date:  2010-01-20       Impact factor: 6.716

4.  Serum Matrix Metalloproteinase-7 is an independent prognostic biomarker in advanced bladder cancer.

Authors:  Mounira El Demery; Gaiané Demirdjian-Sarkissian; Simon Thezenas; William Jacot; Yassine Laghzali; Bruno Darbouret; Stéphane Culine; Xavier Rebillard; Pierre-Jean Lamy
Journal:  Clin Transl Med       Date:  2014-10-28

5.  Allele-specific regulation of matrix metalloproteinase-7 promoter activity is associated with coronary artery luminal dimensions among hypercholesterolemic patients.

Authors:  S Jormsjö; C Whatling; D H Walter; A M Zeiher; A Hamsten; P Eriksson
Journal:  Arterioscler Thromb Vasc Biol       Date:  2001-11       Impact factor: 8.311

6.  MMP1, 2, 3, 7, and 9 gene polymorphisms and urinary cancer risk: a meta-analysis.

Authors:  Liu Tao; Zuo Li; Li Lin; Yin Lei; Yu Hongyuan; Jing Hongwei; Liu Yang; Kong Chuize
Journal:  Genet Test Mol Biomarkers       Date:  2015-08-24

Review 7.  Molecular determinants of metalloproteinase substrate specificity: matrix metalloproteinase substrate binding domains, modules, and exosites.

Authors:  Christopher M Overall
Journal:  Mol Biotechnol       Date:  2002-09       Impact factor: 2.695

Review 8.  Matrix metalloproteinase (MMP) -2, -7 and -9 promoter polymorphisms in colorectal cancer in ethnic Kashmiri population - A case-control study and a mini review.

Authors:  Mujeeb Zafar Banday; Aga Syed Sameer; Ashaq Hussain Mir; Taseem A Mokhdomi; Nissar A Chowdri; Ehtishamul Haq
Journal:  Gene       Date:  2016-05-21       Impact factor: 3.688

9.  Bladder cancer risk associated with genotypic polymorphism of the matrix metalloproteinase-1 and 7 in North Indian population.

Authors:  Priyanka Srivastava; Ruchika Gangwar; Rakesh Kapoor; Rama D Mittal
Journal:  Dis Markers       Date:  2010       Impact factor: 3.434

10.  High VEGF-D and Low MMP-2 Serum Levels Predict Nodal-Positive Disease in Invasive Bladder Cancer.

Authors:  Tobias Benoit; Etienne X Keller; Pirmin Wolfsgruber; Thomas Hermanns; Michele Günthart; Irina Banzola; Tullio Sulser; Maurizio Provenzano; Cédric Poyet
Journal:  Med Sci Monit       Date:  2015-08-04
View more
  7 in total

1.  Epidemiological Evidence Between Variants in Matrix Metalloproteinases-2, -7, and -9 and Cancer Risk.

Authors:  Chenglu Huang; Suqin Xu; Zhilin Luo; Dong Li; Rui Wang; Tianhu Wang
Journal:  Front Oncol       Date:  2022-04-28       Impact factor: 5.738

2.  MUC4 isoforms expression profiling and prognosis value in Chinese melanoma patients.

Authors:  Jinyu Yu; Longwen Xu; Junya Yan; Jiayi Yu; Xiaowen Wu; Jie Dai; Jun Guo; Yan Kong
Journal:  Clin Exp Med       Date:  2020-03-14       Impact factor: 3.984

Review 3.  The Interplay between Oxidative Stress, Inflammation and Angiogenesis in Bladder Cancer Development.

Authors:  Paulina Wigner; Radosław Grębowski; Michał Bijak; Joanna Saluk-Bijak; Janusz Szemraj
Journal:  Int J Mol Sci       Date:  2021-04-25       Impact factor: 5.923

4.  Investigation of Leptin G19A polymorphism with bladder cancer risk: A case-control study.

Authors:  Fei Mao; Xiao-Bing Niu; Shuo Gu; Lu Ji; Bing-Jian Wei; Heng-Bing Wang
Journal:  J Clin Lab Anal       Date:  2020-05-03       Impact factor: 2.352

5.  The impact of genetic variants in the CYP2C8 gene on bladder cancer susceptibility.

Authors:  Weixing Qu; Fuzhou Zhang; Yongyi Cheng; Jing Li; Jiancheng Zhou
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-28       Impact factor: 6.055

Review 6.  Genetic susceptibility of bladder cancer in the Lebanese population.

Authors:  Hampig Raphael Kourie; Bahaa Succar; Eliane Chouery; Cybel Mehawej; Nizar Ahmadieh; Joseph Zouein; Avedis Mardirossian; Nadine Jalkh; Ghassan Sleilaty; Joseph Kattan; Elie Nemr
Journal:  BMC Med Genomics       Date:  2022-10-17       Impact factor: 3.622

7.  Impact of Matrix Metalloproteinases 11 Gene Variants on Urothelial Cell Carcinoma Development and Clinical Characteristics.

Authors:  Chien-Chang Li; Ming-Ju Hsieh; Shian-Shiang Wang; Sheng-Chun Hung; Chia-Yen Lin; Chi-Wen Kuo; Shun-Fa Yang; Ying-Erh Chou
Journal:  Int J Environ Res Public Health       Date:  2020-01-11       Impact factor: 3.390

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.